Table 1.
Patient Group Characteristics—Medical
Variable | Severe CAP | Non-severe CAP | p value |
---|---|---|---|
n = 21 | n = 19 | ||
n (%) | n (%) | ||
Demographics | |||
Age > 65 | 10 (48) | 2 (11) | 0.035 |
Age, median (IQR) | 63.5 (20) | 51.5 (7.5) | <0.001 |
Male gender | 19 (90) | 15 (79) | 1 |
Nursing home resident | 1 (5) | 1 (5) | 1 |
Past medical history | |||
Smoking | 7 (33) | 9 (47) | 0.335 |
Neurologic diseases | 0 (0) | 3 (16) | 0.089 |
Cerebrovascular diseases | 6 (29) | 0 (0) | 0.022 |
Chronic heart failure | 11 (52) | 2 (11) | 0.008 |
COPD | 11 (52) | 3 (16) | 0.049 |
Diabetes mellitus | 8 (38) | 4 (21) | 0.322 |
HIV infection | 0 (0) | 3 (16) | 0.083 |
Acute renal diseases | 3 (14) | 0 (0) | 0.238 |
Chronic renal diseases | 3 (14) | 2 (11) | 1 |
Hepatic diseases | 2 (10) | 0 (0) | 0.49 |
Neoplastic diseases | 4 (19) | 0 (0) | 0.11 |
Hyperlipidemia | 11 (52) | 4 (21) | 0.104 |
Statin therapy | 8 (38) | 3 (16) | 0.286 |
Clinical, laboratory and radiological findings | |||
Altered mental status | 3 (14) | 0 (0) | 0.238 |
Pleural effusion | 9 (43) | 3 (16) | 0.165 |
ICU admission | 10 (48) | 3 (16) | 0.09 |
HCAP | 5 (24) | 5 (27) | 0.731 |
Pneumococcal Pna | 5 (24) | 4 (21) | 1 |
Macrolide therapy | 5 (24) | 9 (47) | 0.101 |
Early TCS (<3 days) | 11 (52) | 15 (79) | 0.046 |
Clinical outcomes | |||
In-hospital mortality | 2 (10) | 1 (5) | 1 |
30 day mortality | 1 (5) | 1 (5) | 1 |
30 day rehospitalization | 2 (10) | 1 (5) | 1 |
COPD chronic obstructive pulmonary disease, HCAP health care-associated pneumonia, Pna pneumonia